A new machine learning model predicts the need for temporary stoma formation after intestinal resection in Crohn’s disease, ...

A 10-year-old Indiana boy with Crohn's disease recently experienced a dream come true thanks to the Sunshine Foundation.

In a phase 2 trial, lusvertikimab significantly improves clinical and endoscopic outcomes in patients with moderate to severe ...

Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...

A groundbreaking investigation from the Technical University of Munich has uncovered a crucial link between mitochondrial dysfunction and Crohn’s disease. This revelation could transform the ...

Teva and Sanofi's duvakitug showed promising results in a Phase 2b study for ulcerative colitis and Crohn's disease, with ...

Tampa Bay Lightning forward Michael Eyssimont was diagnosed with Crohn's disease eight years ago at the age of 21. Since then ...

Focus on Precision Medicine: Certification covers Biomerica's food intolerance products developed to support patients with Crohn's Disease and Ulcerative Colitis (UC), both of which are chronic and ...

It basically kept getting passed off as, like, anxiety or stress since I was meeting someone new and eating new foods...” ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Eli Lilly and Company is unveiling its new 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, which will be available ...